Wegovy weight loss injections UK — The Weight Clinic Skip to content
The Weight Clinic
Prescription-only medicine · available only after a clinical consultation with our prescriber
HomeTreatmentsWegovy
Weight-loss medication

Wegovy — proven for years, properly supervised.

Medically reviewed by Ali Al Sibahi, Pharmacist Independent Prescriber (GPhC 2225108)

Wegovy (semaglutide) is a once-weekly injection licensed in the UK for weight management. It was the first GLP-1 receptor agonist licensed for weight loss, and has the broadest clinical evidence base of any treatment in this class. Prescribed only after a full clinical review and a video consultation with our specialist weight-loss prescriber.

Active ingredientSemaglutide
AdministrationOnce-weekly injection
Dose range0.25mg – 7.2mg
From£115 / month
Check if you're eligible
✓ Free consultation✓ UK-registered clinician✓ No commitment
Wegovy FlexTouch pen (semaglutide)
Specialist video consult
A clinician reviews and approves you before anything is dispensed
Access to clinicians on demand
Message a clinician any time, or jump on a video call — real support whenever you need it
How it works

The original GLP-1 for weight loss.

Semaglutide is the active ingredient in Wegovy. It is a GLP-1 receptor agonist — it mimics the action of a hormone called glucagon-like peptide-1 that your gut naturally releases after you eat. GLP-1 plays a central role in how you feel full, how quickly food leaves your stomach, and how your body regulates blood sugar.

By activating the GLP-1 receptor more strongly and for longer than the body's own signal, Wegovy reduces appetite, slows gastric emptying, and improves blood sugar control. The effect is that you feel fuller sooner and for longer after eating. Like all weight-loss medications, it works alongside dietary and activity changes — not as a replacement for them.

Wegovy was the first medication in this class to be licensed by the MHRA specifically for weight management in adults with obesity, or with overweight plus a weight-related health condition. It's a prescription-only medicine and must be prescribed by a UK-registered clinician after proper assessment.

Side effects

What you might experience.

Most people experience some side effects, especially when starting treatment or increasing dose. They usually settle over a few weeks. The list below isn't exhaustive — see the full SmPC on eMC for complete information.

Common

Affects > 1 in 10
  • Nausea
  • Diarrhoea
  • Constipation
  • Vomiting
  • Decreased appetite
  • Fatigue

Uncommon

Affects 1 in 100 to 1 in 10
  • Dizziness
  • Abdominal pain or discomfort
  • Injection site reactions
  • Hair loss
  • Gallstones
  • Hypoglycaemia (with type 2 diabetes)

Serious but rare

Seek medical attention
  • Severe allergic reaction
  • Acute pancreatitis (persistent severe stomach pain)
  • Severe hypoglycaemia
  • Severe gastrointestinal disease
  • Diabetic retinopathy worsening
!

Report any side effect. If you experience a suspected side effect, tell your clinician and report it via the MHRA Yellow Card scheme. Yellow Card reporting helps the MHRA monitor the safety of all medicines.

Eligibility

Who can — and can't — take this.

Wegovy is a powerful, licensed medicine — and like any powerful medicine, it isn't right for everyone. Your clinician will assess your full history during consultation.

Wegovy may be suitable if you

  • Are aged 18 or over
  • Have a BMI of 30 or above (obesity)
  • Have a BMI of 27–30 with a weight-related condition (e.g., type 2 diabetes, high blood pressure, sleep apnoea)
  • Can safely self-administer a weekly subcutaneous injection
  • Are committed to supporting your treatment with diet and activity changes

Wegovy is not suitable if you

  • Are pregnant, planning pregnancy, or breastfeeding
  • Have type 1 diabetes
  • Have a personal or family history of medullary thyroid carcinoma or MEN2
  • Have a history of pancreatitis
  • Have severe gastrointestinal disease (e.g., gastroparesis)
  • Have active eating disorders
  • Have severe liver or kidney impairment (case-by-case review)
  • Are allergic to semaglutide or any excipient

These lists aren't exhaustive — your clinician reviews your full medical history and current medicines before prescribing.

Transparent pricing

One monthly price. Clearly priced.

Your monthly price covers the medication, pen device and needles. A sharps bin, wipes and other items can be added at checkout — no subscription lock-ins and no hidden fees. Start at the lowest dose and escalate under clinical supervision.

DoseStagePrice / mo*
0.25mgStarter · Week 1–4£115
0.5mgEscalation · Week 5–8£125
1mgEscalation · Week 9–12£135
1.7mgHigher maintenance£175
2.4mgHigh maintenance£230
7.2mgMaximum licensed dose£245

* Standard monthly prices shown. You always see the exact price for your dose, including tracked delivery, before you pay.

Good to know

Wegovy questions.

The things patients most often ask before starting. Still unsure? Our pharmacy team is happy to help.

Check your eligibility
How does Wegovy work?
Semaglutide, the active ingredient in Wegovy, is a GLP-1 receptor agonist — it mimics a natural gut hormone that helps control appetite. You feel fuller sooner and for longer, your stomach empties more slowly, and your blood-sugar control improves, so you naturally eat less. It works alongside diet and activity changes, not instead of them.
How much weight can you lose on Wegovy?
In the STEP UP clinical trial, adults on the 7.2mg dose lost on average 20.7% of their body weight over 72 weeks, alongside lifestyle support. Individual results vary and not everyone reaches this.
What are the most common Wegovy side effects?
Most side effects are digestive — nausea, diarrhoea and constipation — and are most noticeable when you first start or move up a dose. They are usually mild and settle as your body adjusts, which is why the dose is increased slowly. Rarely, more serious problems such as pancreatitis can occur, so your prescriber explains which warning signs to watch for.
How do you take Wegovy?
It is a once-a-week injection given just under the skin of your tummy, thigh or upper arm using a pre-filled pen, rotating the site each week. Most people find it quick and nearly painless. You can add a sharps bin and alcohol swabs to your order.
Who can be prescribed Wegovy?
Generally adults with a BMI of 30 or above, or 27 or above with a weight-related condition such as type 2 diabetes or high blood pressure (lower thresholds may apply for some ethnic backgrounds). It is not suitable for everyone — a pharmacist prescriber reviews your full medical history and decides whether it is appropriate for you.
What is the difference between Wegovy and Mounjaro?
Both are once-weekly GLP-1 injections that reduce appetite. Wegovy (semaglutide) acts on one receptor and has the longest real-world track record; Mounjaro (tirzepatide) acts on two receptors and has shown higher average weight loss in trials. Neither is automatically better — your pharmacist prescriber helps you choose the right one for you.
Compare treatments

Not sure Wegovy is right for you?

Explore the alternatives, or start the free check and your prescriber recommends the best fit for you.

Mounjaro (tirzepatide) Wegovy Tablet Compare all treatments

Start with the eligibility check.

Free consultation. Reviewed by a UK-registered clinician. Refund in full if we decline treatment. No credit card required to start.

Check eligibility